Adial Pharmaceuticals, Inc. (AZR) stock
AZRNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ADIL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Oct 21, 2026Score 5/30
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Adial Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Adial Pharmaceuticals's price to book ratio was 1.4× on Jul 31, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.3× to 16.4×, with a median of 1.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 1.4× | +0.2 |
| 2025 | Dec 31, 2025 | 1.2× | +0.1 |
| 2024 | Dec 31, 2024 | 1.1× | +0.1 |
| 2023 | Dec 29, 2023 | 1.0× | −0.1 |
| 2022 | Dec 30, 2022 | 1.1× | −6.6 |
| 2021 | Dec 31, 2021 | 7.7× | +4.3 |
| 2020 | Dec 31, 2020 | 3.4× | +0.6 |
| 2019 | Dec 31, 2019 | 2.8× | −4.0 |
| 2018 | Dec 31, 2018 | 6.8× | – |